Ascelia Pharma AB (publ)

OM:ACE Stock Report

Market Cap: kr347.0m

Ascelia Pharma Management

Management criteria checks 3/4

Ascelia Pharma's CEO is Magnus Corfitzen, appointed in Jan 2014, has a tenure of 10.33 years. total yearly compensation is SEK4.27M, comprised of 49% salary and 51% bonuses, including company stock and options. directly owns 0.98% of the company’s shares, worth SEK3.40M. The average tenure of the management team and the board of directors is 5.3 years and 7.3 years respectively.

Key information

Magnus Corfitzen

Chief executive officer

kr4.3m

Total compensation

CEO salary percentage49.0%
CEO tenure10.3yrs
CEO ownership1.0%
Management average tenure5.3yrs
Board average tenure7.3yrs

Recent management updates

Recent updates

Is Ascelia Pharma (STO:ACE) In A Good Position To Invest In Growth?

May 11
Is Ascelia Pharma (STO:ACE) In A Good Position To Invest In Growth?

Ascelia Pharma (STO:ACE) Is In A Good Position To Deliver On Growth Plans

Aug 05
Ascelia Pharma (STO:ACE) Is In A Good Position To Deliver On Growth Plans

We Think Ascelia Pharma (STO:ACE) Can Afford To Drive Business Growth

Jan 24
We Think Ascelia Pharma (STO:ACE) Can Afford To Drive Business Growth

We Think Ascelia Pharma (STO:ACE) Can Afford To Drive Business Growth

Aug 23
We Think Ascelia Pharma (STO:ACE) Can Afford To Drive Business Growth

Companies Like Ascelia Pharma (STO:ACE) Are In A Position To Invest In Growth

May 19
Companies Like Ascelia Pharma (STO:ACE) Are In A Position To Invest In Growth

Here's What Ascelia Pharma AB (publ)'s (STO:ACE) Shareholder Ownership Structure Looks Like

Mar 07
Here's What Ascelia Pharma AB (publ)'s (STO:ACE) Shareholder Ownership Structure Looks Like

Helena Wennerström Is The Independent Director of Ascelia Pharma AB (publ) (STO:ACE) And They Just Picked Up 125% More Shares

Dec 09
Helena Wennerström Is The Independent Director of Ascelia Pharma AB (publ) (STO:ACE) And They Just Picked Up 125% More Shares

We Think Ascelia Pharma (STO:ACE) Can Afford To Drive Business Growth

Nov 26
We Think Ascelia Pharma (STO:ACE) Can Afford To Drive Business Growth

CEO Compensation Analysis

How has Magnus Corfitzen's remuneration changed compared to Ascelia Pharma's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023kr4mkr2m

-kr109m

Sep 30 2023n/an/a

-kr152m

Jun 30 2023n/an/a

-kr157m

Mar 31 2023n/an/a

-kr139m

Dec 31 2022kr5mkr2m

-kr131m

Sep 30 2022n/an/a

-kr113m

Jun 30 2022n/an/a

-kr115m

Mar 31 2022n/an/a

-kr126m

Dec 31 2021kr15mkr2m

-kr126m

Sep 30 2021n/an/a

-kr127m

Jun 30 2021n/an/a

-kr113m

Mar 31 2021n/an/a

-kr111m

Dec 31 2020kr5mkr2m

-kr99m

Sep 30 2020n/an/a

-kr90m

Jun 30 2020n/an/a

-kr88m

Mar 31 2020n/an/a

-kr71m

Dec 31 2019kr3mkr992k

-kr66m

Sep 30 2019n/an/a

-kr46m

Jun 30 2019n/an/a

-kr37m

Mar 31 2019n/an/a

-kr30m

Dec 31 2018n/an/a

-kr23m

Sep 30 2018n/an/a

-kr22m

Jun 30 2018kr4mkr1m

-kr24m

Compensation vs Market: Magnus's total compensation ($USD393.54K) is above average for companies of similar size in the Swedish market ($USD253.75K).

Compensation vs Earnings: Magnus's compensation has been consistent with company performance over the past year.

CEO

Magnus Corfitzen (48 yo)

10.3yrs

Tenure

kr4,265,000

Compensation

Mr. Magnus O. Corfitzen serves as the Chief Executive Officer at Ascelia Pharma AB since 2014. He serves as a Director of NsGene A/S. He serves as a Director of DentoFit A/S.Mr. Corfitzen serves on the bo...

Leadership Team

NamePositionTenureCompensationOwnership
Magnus Corfitzen
Chief Executive Officer10.3yrskr4.27m0.98%
SEK 3.4m
Andreas Norlin
Chief Scientific Officer1.6yrsno data0.048%
SEK 167.3k
Mikael Widell
Head of IR & Communications6.3yrsno datano data
Julie Brogren
Deputy CEO & Chief Commercial Officer4.3yrsno data0.30%
SEK 1.0m
Carin Linde
VP of Pharmaceutical Developmentno datano data1.2%
SEK 4.2m

5.3yrs

Average Tenure

51yo

Average Age

Experienced Management: ACE's management team is seasoned and experienced (5.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Peter Benson
Independent Chairman of the Board of Directors7.3yrskr571.00k0.32%
SEK 1.1m
Niels Mengel
Independent Director24.3yrskr320.00k3.71%
SEK 12.9m
Hans Maier
Independent Director7.3yrskr283.00k0.059%
SEK 205.6k
Lauren Barnes
Independent Director4yrskr356.00kno data
Helena Wennerström
Independent Director7.3yrskr363.00k0.089%
SEK 308.4k

7.3yrs

Average Tenure

68yo

Average Age

Experienced Board: ACE's board of directors are considered experienced (7.3 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.